NAV
$24.67
AUM
$20.3M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.70
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +1.56% | -0.80% | -0.92% | +3.91% | +3.15% | +0.77% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ACTG | Acacia Research Corp | 9.94% |
| 2 | PAAS.TO | Pan American Silver Corp | 4.40% |
| 3 | BIP-UN.TO | Brookfield Infrastructure Partners LP | 4.32% |
| 4 | RPRX | Royalty Pharma PLC Class A | 3.67% |
| 5 | GNRC | Generac Holdings Inc | 3.41% |
| 6 | RGLD | Royal Gold Inc | 3.31% |
| 7 | ARLP | Alliance Resource Partners LP | 2.97% |
Under normal market conditions, the fund seeks to meet its investment objective by investing primarily in equity securities, including common stocks, preferred stocks, related depository receipts, REITs, and other equity investments or ownership interests in business enterprises. It invests predominantly in common stocks. The fund’s derivative investments may include, among other instruments: (i) options; (ii) volatility-linked ETFs; (iii) volatility-linked exchange-traded notes (“ETNs”). It is non-diversified.
Inception Date: 2021-04-29